Agata Patel

Agata Patel is a Senior Scientist, specializing in pre-clinical research for Adaptimmune. Prior to their current role, Agata held positions at Oxford Biomedica and University of Oxford, where Agata focused on CAR T cell therapy development and gene editing using CRISPR-Cas9 technology. With a background in radiation biology and genetics, Agata has a strong research history in investigating genetic factors in cancer susceptibility and treatment. Agata holds a Doctor of Philosophy in Radiation Biology/Radiobiology from the University of Oxford, a Master of Science in Genetics from the University of Cologne, and Bachelor degrees in Biotechnology and Molecular Biology.